IMMUNITYBIO INC (IBRX)

US45256X1037 - Common Stock

5.035  +0.16 (+3.28%)

After market: 5.1 +0.06 (+1.29%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to IBRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.5. This target is 29.15% above the current price.
IBRX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about IBRX.
In the previous month the buy percentage consensus was at a similar level.
IBRX was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 5.044.806.506.508.40 - -4.72% 29.15% 29.15% 66.83%

Related screens

Up and Down Grades
Date Firm Action Rating
2024-11-21 D. Boral Capital Maintains Buy -> Buy
2024-11-19 D. Boral Capital Maintains Buy -> Buy
2024-11-12 D. Boral Capital Maintains Buy -> Buy
2024-10-23 EF Hutton Initiate Buy
2024-08-19 Piper Sandler Maintains Neutral -> Neutral
2024-04-29 Piper Sandler Maintains Neutral -> Neutral
2024-03-25 Piper Sandler Maintains Neutral -> Neutral
2023-05-12 Piper Sandler Downgrade Overweight -> Neutral
2022-08-03 Jefferies Initiate Buy